<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: It is important to identify factors responsible for the development of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (BO) </plain></SENT>
<SENT sid="1" pm="."><plain>The effect of <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> (<z:chebi fb="4" ids="53266">PPIs</z:chebi>) on oesophageal clearance of both acid and alkaline reflux in these patients is uncertain and studies comparing BO patients and healthy controls (HCs) have not been performed earlier </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Two groups of patients were studied: 18 HCs and 12 BO patients </plain></SENT>
<SENT sid="3" pm="."><plain>Oesophageal motility, <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> and duodenogastro-<z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">oesophageal reflux</z:e> (DGOR) were measured using a three-pressure transducer catheter with an <z:chebi fb="24" ids="30304,30513">antimony</z:chebi> pH tip, connected to a <z:chebi fb="33" ids="29101">sodium ion</z:chebi> selective electrode </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were studied both on and off <z:chebi fb="4" ids="53266">PPIs</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Without <z:chebi fb="4" ids="53266">PPI</z:chebi> therapy, BO patients had significantly more upright and supine <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> and upright DGOR compared with HCs </plain></SENT>
<SENT sid="6" pm="."><plain>During <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e>, HC demonstrated more peristalsis than BO [HC, % peristalsis=64 (9), BO=53 (8), P&lt;0.01], but this was not seen during DGOR </plain></SENT>
<SENT sid="7" pm="."><plain>[HC, % peristalsis=68 (14), BO=56 (11)] </plain></SENT>
<SENT sid="8" pm="."><plain>In Barrett's patients, DGOR was significantly reduced with <z:chebi fb="4" ids="53266">PPIs</z:chebi> [off <z:chebi fb="4" ids="53266">PPI</z:chebi>, % upright DGOR=61 (17), on <z:chebi fb="4" ids="53266">PPIs</z:chebi>=19 (15), P&lt;0.01], and no oesophageal motility differences were seen compared with results without <z:chebi fb="4" ids="53266">PPIs</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: HCs demonstrate better oesophageal motility compared with BO patients to prevent acid and alkaline reflux </plain></SENT>
<SENT sid="10" pm="."><plain>When <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> occurred, HCs had better coordinated motility to remove it </plain></SENT>
<SENT sid="11" pm="."><plain>This increased coordination did not occur during DGOR, suggesting different stimulation mechanisms </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="4" ids="53266">PPI</z:chebi> reduced DGOR in BO patients, without any change in oesophageal motility </plain></SENT>
</text></document>